Gauging the acceptability of HIV vaccines: An exploratory study examining knowledge, attitudes, and beliefs among injecting drug users in Viet Nam

Journal of Ethnic and Cultural Diversity in Social Work

Volumn 16, Issue 1-2, 2007, Pages 161-192

  Nguyen, France ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Barriers; HIV; Injecting drug users; Vaccine; Viet Nam

Indexed keywords

EID: 34548486024     PISSN: 15313204     EISSN: 15313212     Source Type: Journal    
DOI: 10.1300/J051v16n01_06     Document Type: Article

References (54)

1. Aylward, R.B., Clements, J., & Olive, J.M. (1997). The impact of immunization control activities on measles outbreaks in middle and low-income countries. International journal of Epidemiology, 26(3), 662-669.
2. Balinska, M.A. (2003). Vaccination in tomorrow's society. The Lancet Infectious Diseases, 3(7), 443-447.
3. Bates, B.R. & Harris, T.M. (2004). The Tuskegee Study of untreated syphilis and public perceptions of biomedical research: A focus group study. Journal of the National Medical Association, 96(8), 1051-1064.
4. Beyrer, C., Razak, M. H., Lisam, K., Chen, J., Lui, W., & Yu, X. F. (2000). Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS, 14, 75-83.
5. Bos JM, & - Postma MJ. (2001). The economics of HIV vaccines: Projecting the impact of HIV vaccination of infants in sub-Saharan Africa. Pharmacoeconomics, 19(9), 937-946.
6. Celentano, D. D., Beyrer, C., Natpratan, C., Eiumtrakul, S., Sussman, L., Renzullo, P. O., Khamboonruang, C., & Nelson, K. E. (1995). Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. AIDS, 9(9), 1079-1083.
7. Cohen, J. (2003). Public Health: AIDS vaccine trial produces disappointment and confusion. Science, 299(5611), 1290-1291.
8. Efroymson, D. (1996). Vietnam faces modern sexuality problems with inadequate knowledge and solutions. Siecus Report, 24(3), 4-6.
9. Esparza J. (2001). An HIV vaccine: How and when?, Bulletin of the World Health Organization 79(12), 1133-1137.
10. Esparza, J., & Osmanov, S. (2003). HIV vaccines: A global perspective. Current Molecular Medicine, 3(3), 183-193.
11. Fasano, M.B., Hayes, J., & Wilson, R. (1986). Traditional beliefs and use of health care services by Vietnamese and Laotian refugees. Texas Medicine, 82(8), 33-36.
12. Frances, D.P., Heyward, W.L., Popovic, V., Orozco-Cronin, P., Prelind, K., Gee, C., Hirsch, A., Ippolito, T., Luck, A., Longhi, M., Gulati, V., Winslow, N., Gurwith, M., Sinangil, F., & Berman, P.W. (2003). Candidate HIV/AIDS vaccines: Lessons learned from the world's first phase III efficacy trials. AIDS, 17, 147-156.
13. Grinstead, O. A. (1995). Social and behavioral issues in phase III HIV preventive vaccine trials. AIDS, 9(Supplement A), S245-S250.
14. Hanke, T. (2001). Prospect of a prophylactic vaccine for HIV. British Medical Bulletin, 58, 205-218.
15. Hanke, T. (2003). Development of prophylactic AIDS vaccines: The current state of affairs. Current Opinion in Molecular Therapeutics, 5(1), 25-32.
16. Henry J. Kaiser Foundation-Daily Briefs. (August 24, 2004). Website: www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=25441
17. Heyward, W. L., MacQueen, K. M., & Goldenthal, K. L. (1998). HIV vaccine development and evaluation: Realistic expectations. AIDS Research and Human Retroviruses, 14(Supplement 3), S205-S210.
18. Jackson, D. J., Martin, H. L. J., Bwayo, J. J., Nyange, P. M., Rakwar, J. P., Kashonga, F., Mandaliya, K., Ndinya-Achola, J. O., & Kreiss, J. K. (1995). Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya. AIDS, 9(11), 1279-1283.
19. Jenkins, R. A., Temoshok, L. R., & Virochsiri, K. (1995). Incentives and disincentives to participate in prophylactic HIV vaccine research. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 9(1), 36-42.
20. Jenkins RA, Torugsa K, Markowitz LE, Mason CJ, Jamroentana V/Brown AE, & Nitayaphan S. (2000). Willingness to participate in HIV-1 vaccine trials among young Thai men. Sexually Transmitted Infections, 76 (5), 386-392.
21. Kahn, J. (1999). Culture and Medicine: Building and testing an effective HIV vaccine. Western Journal of Medicine, 171(5-6), 363-365.
22. Kibria, N. (1993). Family tightrope: The changing live of Vietnamese Americans. Princeton, NJ: Princeton University Press.
23. Klein, E., & Ho, R. J. (2000). Challenges in the development of an effective HIV vaccine: Current approaches and future directions. Clinical Therapy, 22(3), 295-314; discussion 265.
24. Klein, M. (2003). Prospects and challenges for prophylactic and therapeutic HIV vaccines. Vaccine, 21(7-8), 616-619.
25. Liau, A., Zimet, G. D., & Fortenberry, J. D. (1998). Attitudes about human immunodeficiency virus immunization: The influence of health beliefs and vaccine characteristics. Sexually Transmitted Diseases 25(2), 76-81.
26. Liau A, & Zimet GD. (2001). The acceptability of HIV immunization: examining vaccine characteristics as determining factors. AIDS Care 13(5), 643-650.
27. Long, N.H., Johansson, E., Lonnroth, K., Eriksson, B., Winkvist, A., & Diwan, V.K. (1999). Longer delays in tuberculosis diagnosis among women in Vietnam. International Journal of Tuberculosis and Lung Disease 3(5), 388-393.
28. Lonnroth, K., Thuong, L.M., Linh, P.D., & Diwan, V.K. (1999). Delay and discontinuity a survey of TB patients' search of a diagnosis in a diversified health care system. International Journal of Tuberculosis and Lung Disease, 3(11), 992- 1000.
29. MacQueen, K. M., Vanichseni, S., Kitayaporn, D., Lin, L. S., Buavirat, A., Naiwatanakul, T., Raktham, S., Mock, P., Heyward, W. L., Des Jarlais, D. C., Choopanya, K., & Mastro, T. D. (1999). Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand. Journal of Acquired Immune Deficiency Syndromes 21(3), 243-251.
30. McCarthy, M. (2003). HIV vaccine fails in phase 3 trial. Lancet, 361(9359), 755-756.
31. Meyers K, Metzger DS, Navaline H, Woody GE, & McLellan AT. (1994). HIV vaccine trials: Will intravenous drug users enroll? American Journal of Public Health, 84(5), 761-766.
32. Miles, M.B., & Huberman, A.M. (1994). Qualitative data analysis. Thousand Oaks, CA: Sage Publications.
33. Nguyen, T.H., Hoang, T.L., Pham, K.C., van Ameijden, E.J., Deville, W., & Wolffers, I. (1999). HIV monitoring in Vietnam: System, methodology, and results of sentinel surveillance. Journal o Acquired Immune Deficiency Syndromes, 21(4), 338-346.
34. Nguyen, T.H., Nguyen, T. L., & Trinh, Q.H. (2004). HIV/AIDS Epidemic in Vietnam: Evolution and Responses. AIDS Education and Prevention, 16(3 Supplement A), 137-154.
35. Nguyen, T.H., & Wolffers, I. (1994). HIV Infection in Vietnam. Lancet 343(8894),410.
36. Newman, P.A., Duan, N., Rudy, E.T., Roberts, K.J., & Swendeman, D. (2004). Post-trial HIV vaccine adoption: Concerns, motivators, and intentions among persons at risk for HIV. Journal of Acquired Immune Deficiency Syndromes, 37(3), 1393-1403.
37. Padgett, D.K. (1998). Qualitative methods in social work research. Thousand Oaks, CA: Sage Publications.
38. Pitisuttithum, P., Berman, P.W., Phonrat, B., Suntharasamai, P., Raktham, S., Srisuwanvilai, L.O., Hirunras, K., Kitayaporn, D., Kaewkangwal, J., Migasena, S., Sheppard, H.W., Li, E., Chernow, M., Peterson, M.L., Shibata, R., Heyward, W.L., & Francis, D.P. (2004). I/II Study of a Candidate Vaccine Designed Against the B and E Subtypes of HIV-1. Journal of Acquired Immune Deficiency Syndromes, 37(l), 1160-1165.
39. Quan, V. M., Chung, A., Long, H. T., & Dondero, T. J. (2000). HIV in Vietnam: The evolving epidernic and the prevention response, 1996 through 1999. Journal of Acquired Immune Deficiency Syndromes, 25, 360-369.
40. Sheon, A.R., Wagner, L., McElrath, M.J., Keefer, M.C., Zimmerman, E., Israel, H., Bergerm, D., & Fast P. (1998). Preventing discrimination against volunteers in prophylactic HIV vaccine trials: Lessons from a phase II trial. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology. 19(5), 519-526.
41. Stewart, D. W., & Shamdasani, P. N. (1990). Focus groups: Theory and practice (Applied Social Research Methods Series No. 20). Newbury Park, CA: Sage Publications.
42. Strauss RP, Sengupta S, Kegeles S, McLellan E, Metzger D, Eyre S, Khanani F, Emrick CB, & MacQueen KM. (200 1). Willingness to volunteer in future preventive HIV vaccine trials: Issues and perspectives from three U.S. communities. Journal of Acquired Immune Deficiency Syndromes, 26(l), 63-71.
43. Streefland, P.H.. (2003). Introduction of a HIV vaccine in developing countries: Social and cultural dimensions. Vaccine, 21(13-14), 1304-1309.
44. Tangcharoensathien V, Phoolcharoen W, Pitayarangsarit S, Kongsin S, Kasemsup V, Tantivess S, & Suraratdecha C. (2001). The potential demand for an AIDS vaccine in Thailand. Health Policy, 57(2), 111-139.
45. Thapinta, D., Jenkins, R. A., Morgan, P. A., Chiu, J., Boenim, W., Bussaratid, V., Chaddic, C., Naksrisook, S., Phonrat, B., Sirijongdee, N., Sornsathapornkul, P., Sontirat, A., Srisaengchai, P., Suwanarach, C., Wongkamhaeng, S., Brown, A. E., Kharuboonruang, C., Nitayaphan, S., Pitisuttithum, P., & Thongchareon, P. (2002). Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand. Journal of Acquired Immune Deficiency Syndromes, 30(5), 503-513.
46. United Nations. (2000). Report on the global HIV/AIDS epidernic (UNAIDS/ 00. 13E, ISBN: 92-9173-000-9). Geneva, Switzerland: Joint United Nations programme on HIV/AIDS.
47. United Nations Joint AIDS Programme (UNAIDS). Website: www.unaids.org
48. United Nations Joint AIDS Programme-Update December 2005 (UNAIDS). Website: http://www.unaids.org/epi/2005/doc/EPlupdate2005_pdf_en/ epi-update2OO5_en.pdf
49. World Health Organization-Hepatitis (WHO-HP). Website: www.who.int/vaccinesdiseases/diseases/hepatitis_b.shtml
50. World Health Organization-Viet Nam (WHO-VN). Website: www.who.int/country/vnm/en/
51. World Health Organization-3x5 Campaign (WHO-3x5). Website: http://www.who.int/3by5/en/
52. World Health Organization Consultation. (2001). Future access to HIV vaccines. AIDS, 15(7), W27-W44.
53. Zimet, G. D., Blythe, M. J., & Fortenberry, J. D. (2000). Vaccine characteristics and acceptability of HIV immunization among adolescents. International Journal of STD and AIDS, 11 (3), 143-149.
54. Zimet, G. D., Liau, A., & Fortenberry, V. D. (1997). Health beliefs and intention to get immunized for HIV. Journal of Adolescent Health, 20(5), 354-359.